Prostate Cancer Clinical Trials in Montvale, New Jersey
11 studies are recruiting for prostate cancer in Montvale, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body ra…
- Stage
- Phase 3
- Ages
- Any age
- Site
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale, New Jersey
- Locations
- 8 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study of Changes to Prostate Procedures
The purpose of this study is to look whether using local anesthesia during a transperineal prostate biopsy, while put to sleep by IV sedation, helps reduce the number of people who feel significant pain in the recovery room. The researchers will also look at how local anesthesia affects the amount …
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see whether these scans may be better able to find places in the body where your prostate cancer may have spread.
- Stage
- Not phased
- Ages
- Any age
- Site
- Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Researching the Effect of Exercise on Cancer
Researchers think that exercise may be able to prevent cancer from coming back by lowering ctDNA levels. The purpose of this study is to explore how aerobic exercise (exercise that stimulates and strengthens the heart and lungs and improves the body's use of oxygen) can reduce the level of ctDNA fo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
- Locations
- 9 in total
- Run by
- City of Hope Medical Center
-
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- MSK Bergen, Montvale, New Jersey
- Locations
- 337 in total
- Run by
- Pfizer
-
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillance for localized prostate cancer.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey
- Locations
- 10 in total
- Run by
- City of Hope Medical Center
-
A Study of a New PET Scanner in People With Cancer
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Consent Only ), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
The purpose of this study is to find out whether tinengotinib in combination with abiraterone acetate and prednisone or enzalutamide is a safe treatment that causes few or mild side effects in people with metastatic castration-resistant prostate cancer (mCRPC).
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
- Locations
- 12 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system to find and kill cancer cells. Researchers will look at whether this treatment approach is able to c…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.